EMMAUS LIFE SCIENCES, INC. (EMMA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseEMMA / S&P -31.80% / 15.20% |
LoseEMMA / S&P 10.98% / 15.00% |
LoseEMMA / S&P 50.00% / 50.40% |
| 2026-Q12/3 |
WinEMMA / S&P 15.38% / -4.33% |
LoseEMMA / S&P -27.33% / 11.30% |
WinEMMA / S&P 85.71% / 27.70% |
| 2025-Q42/3 |
WinEMMA / S&P 18.18% / 2.65% |
LoseEMMA / S&P -25.22% / 9.00% |
WinEMMA / S&P 20.00% / 13.40% |
| 2025-Q31/3 |
LoseEMMA / S&P -15.38% / 8.12% |
LoseEMMA / S&P -41.78% / 4.61% |
WinEMMA / S&P 140.00% / 13.45% |
| 2025-Q20/3 |
LoseEMMA / S&P -23.98% / 10.94% |
LoseEMMA / S&P -29.92% / 4.83% |
LoseEMMA / S&P -33.33% / 10.63% |
| 2025-Q11/3 |
WinEMMA / S&P 101.18% / -4.27% |
LoseEMMA / S&P -34.70% / 4.98% |
LoseEMMA / S&P -22.22% / 10.57% |
| 2024-Q41/3 |
LoseEMMA / S&P -71.48% / 2.41% |
LoseEMMA / S&P -43.73% / 5.25% |
WinEMMA / S&P 11.11% / 6.15% |
| 2024-Q30/3 |
LoseEMMA / S&P -70.54% / 5.89% |
LoseEMMA / S&P -28.22% / 5.89% |
LoseEMMA / S&P -50.00% / 6.11% |
| 2024-Q20/3 |
LoseEMMA / S&P -3.67% / 4.28% |
LoseEMMA / S&P -29.64% / 5.38% |
LoseEMMA / S&P -10.00% / 5.12% |
| 2024-Q11/3 |
LoseEMMA / S&P 4.92% / 10.56% |
WinEMMA / S&P 15.71% / 5.71% |
LoseEMMA / S&P -64.00% / 5.59% |
| 2023-Q41/3 |
LoseEMMA / S&P -19.94% / 11.69% |
WinEMMA / S&P 60.94% / 6.81% |
LoseEMMA / S&P -57.14% / 7.78% |
| 2023-Q31/3 |
LoseEMMA / S&P -45.65% / -3.27% |
WinEMMA / S&P 83.85% / 7.52% |
LoseEMMA / S&P -72.22% / -5.03% |
| 2023-Q21/3 |
LoseEMMA / S&P -23.97% / 8.74% |
WinEMMA / S&P 74.04% / 9.50% |
LoseEMMA / S&P -75.61% / -8.57% |
| 2023-Q13/3 |
WinEMMA / S&P 16.21% / 7.50% |
WinEMMA / S&P 18.37% / 10.77% |
WinEMMA / S&P 38.89% / -15.69% |
| 2022-Q41/3 |
WinEMMA / S&P 53.12% / 7.56% |
LoseEMMA / S&P -10.77% / 11.88% |
LoseEMMA / S&P EMMA unavailable / -17.99% |
| 2022-Q30/3 |
LoseEMMA / S&P -62.22% / -4.88% |
LoseEMMA / S&P -35.07% / 13.47% |
LoseEMMA / S&P EMMA unavailable / -1.41% |
| 2022-Q20/3 |
LoseEMMA / S&P -55.00% / -16.10% |
LoseEMMA / S&P -31.13% / 13.71% |
LoseEMMA / S&P EMMA unavailable / 11.04% |
| 2022-Q10/3 |
LoseEMMA / S&P -40.12% / -4.60% |
LoseEMMA / S&P -14.10% / 15.97% |
LoseEMMA / S&P EMMA unavailable / 42.23% |
| 2021-Q40/3 |
LoseEMMA / S&P 4.37% / 11.03% |
LoseEMMA / S&P -11.04% / 15.00% |
LoseEMMA / S&P EMMA unavailable / 96.40% |
| 2021-Q31/3 |
WinEMMA / S&P 12.68% / 0.58% |
LoseEMMA / S&P 0.57% / 10.77% |
LoseEMMA / S&P EMMA unavailable / 69.42% |
| 2021-Q20/3 |
LoseEMMA / S&P -16.96% / 8.55% |
LoseEMMA / S&P -0.79% / 6.58% |
LoseEMMA / S&P EMMA unavailable / 51.81% |
| 2021-Q11/3 |
WinEMMA / S&P 39.02% / 6.17% |
LoseEMMA / S&P -13.80% / -1.06% |
LoseEMMA / S&P EMMA unavailable / 7.39% |
| 2020-Q42/3 |
WinEMMA / S&P 26.80% / 12.15% |
WinEMMA / S&P 1.82% / -3.72% |
LoseEMMA / S&P EMMA unavailable / -33.42% |
| 2020-Q31/3 |
LoseEMMA / S&P -41.92% / 8.93% |
WinEMMA / S&P -1.97% / -2.04% |
LoseEMMA / S&P EMMA unavailable / -27.10% |
| 2020-Q22/3 |
WinEMMA / S&P 39.17% / 20.54% |
WinEMMA / S&P 2.40% / -0.46% |
LoseEMMA / S&P EMMA unavailable / -27.11% |
| 2020-Q11/3 |
LoseEMMA / S&P -39.09% / -19.60% |
WinEMMA / S&P 37.32% / 3.47% |
LoseEMMA / S&P EMMA unavailable / -14.75% |
| 2019-Q41/3 |
LoseEMMA / S&P -17.92% / 9.07% |
WinEMMA / S&P 63.01% / 5.36% |
LoseEMMA / S&P EMMA unavailable / 2.99% |
| 2019-Q31/3 |
LoseEMMA / S&P -69.23% / 1.70% |
WinEMMA / S&P 313.01% / 5.02% |
LoseEMMA / S&P EMMA unavailable / 0.21% |
| 2019-Q21/3 |
LoseEMMA / S&P -5.80% / 4.30% |
WinEMMA / S&P 2213.02% / 6.64% |
LoseEMMA / S&P EMMA unavailable / 8.65% |
| 2019-Q12/3 |
WinEMMA / S&P 88.52% / 13.65% |
WinEMMA / S&P 2673.84% / 8.12% |
LoseEMMA / S&P EMMA unavailable / 14.29% |
| 2018-Q40/3 |
LoseEMMA / S&P -53.67% / -13.52% |
LoseEMMA / S&P EMMA unavailable / 9.05% |
LoseEMMA / S&P EMMA unavailable / 18.23% |
| 2018-Q30/3 |
LoseEMMA / S&P -13.19% / 7.71% |
LoseEMMA / S&P EMMA unavailable / 10.21% |
LoseEMMA / S&P EMMA unavailable / 19.06% |
| 2018-Q21/3 |
WinEMMA / S&P 52.94% / 3.43% |
LoseEMMA / S&P EMMA unavailable / 9.03% |
LoseEMMA / S&P EMMA unavailable / 14.46% |
| 2018-Q10/3 |
LoseEMMA / S&P -65.00% / -0.76% |
LoseEMMA / S&P EMMA unavailable / 7.68% |
LoseEMMA / S&P EMMA unavailable / 12.46% |
| 2017-Q40/3 |
LoseEMMA / S&P -10.76% / 6.64% |
LoseEMMA / S&P EMMA unavailable / 7.03% |
LoseEMMA / S&P EMMA unavailable / 13.82% |
| 2017-Q30/3 |
LoseEMMA / S&P -41.38% / 4.48% |
LoseEMMA / S&P EMMA unavailable / 5.68% |
LoseEMMA / S&P EMMA unavailable / 17.57% |
| 2017-Q21/3 |
WinEMMA / S&P 10.17% / 3.09% |
LoseEMMA / S&P EMMA unavailable / 4.83% |
LoseEMMA / S&P EMMA unavailable / 17.74% |
| 2017-Q10/3 |
LoseEMMA / S&P -34.81% / 6.07% |
LoseEMMA / S&P EMMA unavailable / 3.67% |
LoseEMMA / S&P EMMA unavailable / 13.32% |
| 2016-Q41/3 |
WinEMMA / S&P 50.83% / 3.82% |
LoseEMMA / S&P EMMA unavailable / 2.09% |
LoseEMMA / S&P EMMA unavailable / 7.05% |
| 2016-Q31/3 |
WinEMMA / S&P 76.47% / 3.85% |
LoseEMMA / S&P EMMA unavailable / 0.20% |
LoseEMMA / S&P EMMA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | EMMA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 661.47% | 20.78% |
| Annualized return | 661.47% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | EMMA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.58% | 83.14% |
| Annualized return | -44.17% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | EMMA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.65% | 319.30% |
| Annualized return | -43.26% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.